Palvella Therapeutics, Inc. Common Stock (PVLA) is a publicly traded Healthcare sector company. As of July 17, 2026, PVLA trades at $156.96 with a market cap of $2.12B and a P/E ratio of -37.37. PVLA moved +6.59% today. Year to date, PVLA is +50.22%; over the trailing twelve months it is +403.49%. Its 52-week range spans $11.17 to $161.38. Analyst consensus is strong buy with an average price target of $235.40. Rallies surfaces PVLA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for PVLA shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $156.96 |
| Market Cap | $2.12B |
| P/E Ratio | -37.37 |
| EPS | $-4.17 |
| Dividend Yield | 0.00% |
| 52-Week High | $161.38 |
| 52-Week Low | $11.17 |
| Volume | 236.28K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.91M |
| Net Income | $-49.30M |
| Gross Margin | 0.00% |
11 analysts cover PVLA: 0 strong buy, 11 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $235.40.